-
AIM ImmunoTech (AIM) Misses Q2 EPS by 360c
-
AIM ImmunoTech (AIM) Files for 1.05 Unit Offering
-
AIM ImmunoTech (AIM) Resumes Trading on NYSE American
-
AIM ImmunoTech (AIM) Announces Trading Under the Ticker AIMI on the Pink Open Market
-
AIM ImmunoTech (AIM) announces NYSE delisting, plans to appeal
-
AIM ImmunoTech (AIM) Halted, News Pending
-
AIM ImmunoTech (AIM) Announces NYSE American Acceptance of Plan to Regain Listing Compliance
-
AIM ImmunoTech (AIM) Announces Election of Three Incumbent Board Members
-
Ted Kellner Issues Letter to AIM ImmunoTech (AIM)
-
AIM ImmunoTech (AIM) Refutes Activist Group’s False and Misleading Claims
-
AIM ImmunoTech (AIM) Announces Cash Conservation Plan
-
Kellner Group Urges Stockholders of AIM Immunotech (AIM) to Vote Gold Card Now for Desperately Needed Change to the AIM Board
-
AIM ImmunoTech (AIM) Misses Q3 EPS by 6c
-
AIM ImmunoTech (AIM) Tops Q2 EPS by 10c

